Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
February 25, 2021 / 10:06 AM IST
Reported Standalone quarterly numbers for Procter & Gamble Health are:Net Sales at Rs 240.22 crore in December 2020 up 1.46% from Rs. 236.77 crore in December 2019.
Quarterly Net Profit at Rs. 67.88 crore in December 2020 up 77.65% from Rs. 38.21 crore in December 2019.
EBITDA stands at Rs. 94.47 crore in December 2020 up 71.51% from Rs. 55.08 crore in December 2019.
Procter&Gamble EPS has increased to Rs. 40.90 in December 2020 from Rs. 23.02 in December 2019.
Procter&Gamble shares closed at 6,864.60 on February 24, 2021 (NSE) and has given 45.71% returns over the last 6 months and 67.13% over the last 12 months.
| Procter & Gamble Health | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'20 | Sep'20 | Dec'19 | | Net Sales/Income from operations | 240.22 | 263.97 | 236.77 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 240.22 | 263.97 | 236.77 | | EXPENDITURE | | Consumption of Raw Materials | 46.67 | 93.05 | 73.51 | | Purchase of Traded Goods | 4.26 | 5.16 | 1.33 | | Increase/Decrease in Stocks | 12.65 | -3.25 | 5.38 | | Power & Fuel | -- | -- | -- | | Employees Cost | 33.49 | 38.69 | 30.24 | | Depreciation | 7.85 | 7.36 | 4.28 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 54.40 | 52.22 | 77.29 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 80.90 | 70.74 | 44.74 | | Other Income | 5.72 | 6.72 | 6.06 | | P/L Before Int., Excpt. Items & Tax | 86.62 | 77.46 | 50.80 | | Interest | 0.19 | 0.24 | -- | | P/L Before Exceptional Items & Tax | 86.43 | 77.22 | 50.80 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 86.43 | 77.22 | 50.80 | | Tax | 18.55 | 17.96 | 12.59 | | P/L After Tax from Ordinary Activities | 67.88 | 59.26 | 38.21 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 67.88 | 59.26 | 38.21 | | Equity Share Capital | 16.60 | 16.60 | 16.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 40.90 | 35.70 | 23.02 | | Diluted EPS | 40.90 | 35.70 | 23.02 | | EPS After Extra Ordinary | | Basic EPS | 40.90 | 35.70 | 23.02 | | Diluted EPS | 40.90 | 35.70 | 23.02 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
